Literature DB >> 9494676

Dengue--a re-emerging infectious disease in Singapore.

K T Goh1.   

Abstract

Despite its well-established integrated nationwide Aedes mosquito control programme which incorporates source reduction, public health education and law enforcement, Singapore has not been spared from the regional resurgence of dengue. The disease incidence has been increasing from 9.3 per 100,000 in 1988 to 102.7 per 100,000 in 1996 at the time when the Aedes house index (HI) has dropped to around 1% from > 25% in the 1960s. Majority of the cases reported from 1990 to 1996 were dengue fever (DF); dengue haemorrhagic fever (DHF) constituted only 6.7%. The case-fatality rate was 0.1% with 13 (81.3%) of 16 serologically confirmed deaths above 19 years of age. The median age has shifted from 14 years in 1973 to 27 years in 1996. The proportion of primary infections also increased from about one-third in 1990 to nearly half in 1996. All four dengue serotypes have been detected from infected persons with dengue 2 predominating in 1990, 1991 and 1993, dengue 3 in 1992 and 1994 and dengue 1 in 1995 and 1996. The disease incidence was significantly correlated with Aedes aegypti HI and residents of compound houses had a significantly higher rate of infection as well as a higher morbidity rate compared with dwellers of high-rise public housing estates. Seroprevalence surveys confirmed the low level of dengue transmission. The immunity level of the general population has been declining with only 6.4% of children and young adults below 25 years of age possessing haemagglutination-inhibition antibody to dengue 2. It would appear that the successful vector control programme over the last two decades has brought about a paradoxical situation in that outbreaks tend to occur more frequently and with even greater intensity because of the low herd immunity of the population. Until the dengue vaccine is commercially available for mass immunisation of the population, community-based integrated control of Aedes aegypti remains the key to the prevention and control of DF/DHF.

Entities:  

Mesh:

Year:  1997        PMID: 9494676

Source DB:  PubMed          Journal:  Ann Acad Med Singap        ISSN: 0304-4602            Impact factor:   2.473


  27 in total

Review 1.  The global distribution of yellow fever and dengue.

Authors:  D J Rogers; A J Wilson; S I Hay; A J Graham
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

2.  Improving dengue virus capture rates in humans and vectors in Kamphaeng Phet Province, Thailand, using an enhanced spatiotemporal surveillance strategy.

Authors:  Stephen J Thomas; Jared Aldstadt; Richard G Jarman; Darunee Buddhari; In-Kyu Yoon; Jason H Richardson; Alongkot Ponlawat; Sopon Iamsirithaworn; Thomas W Scott; Alan L Rothman; Robert V Gibbons; Louis Lambrechts; Timothy P Endy
Journal:  Am J Trop Med Hyg       Date:  2015-05-18       Impact factor: 2.345

3.  Forty Years of Dengue Surveillance at a Tertiary Pediatric Hospital in Bangkok, Thailand, 1973-2012.

Authors:  Ananda Nisalak; Hannah E Clapham; Siripen Kalayanarooj; Chonticha Klungthong; Butsaya Thaisomboonsuk; Stefan Fernandez; Julia Reiser; Anon Srikiatkhachorn; Louis R Macareo; Justin T Lessler; Derek A T Cummings; In-Kyu Yoon
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

4.  Leptospirosis and malaria as causes of febrile illness during a dengue epidemic in Jamaica.

Authors:  John Lindo; Paul D Brown; Ivan Vickers; Michelle Brown; Sandra T Jackson; Eva Lewis-Fuller
Journal:  Pathog Glob Health       Date:  2013-09       Impact factor: 2.894

5.  Review of Dengue hemorrhagic fever fatal cases seen among adults: a retrospective study.

Authors:  Sing-Sin Sam; Sharifah Faridah Syed Omar; Boon-Teong Teoh; Juraina Abd-Jamil; Sazaly AbuBakar
Journal:  PLoS Negl Trop Dis       Date:  2013-05-02

6.  Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore.

Authors:  Yee Sin Leo; Anneliese Wilder-Smith; Sophia Archuleta; Lynette P Shek; Chia-Yin Chong; Hoe Nam Leong; Chian Yong Low; May-Lin Helen Oh; Alain Bouckenooghe; T Anh Wartel; Denis Crevat
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

7.  Dengue hemorrhagic fever, Uttaradit, Thailand.

Authors:  Jayanton Patumanond; Chamaiporn Tawichasri; Seree Nopparat
Journal:  Emerg Infect Dis       Date:  2003-10       Impact factor: 6.883

8.  Seroepidemiology of dengue virus infection in the adult population in tropical Singapore.

Authors:  L W Ang; J Cutter; L James; K T Goh
Journal:  Epidemiol Infect       Date:  2014-09-23       Impact factor: 4.434

Review 9.  Use of mapping and spatial and space-time modeling approaches in operational control of Aedes aegypti and dengue.

Authors:  Lars Eisen; Saul Lozano-Fuentes
Journal:  PLoS Negl Trop Dis       Date:  2009-04-28

10.  Climate change and developing-country cities: implications for environmental health and equity.

Authors:  Diarmid Campbell-Lendrum; Carlos Corvalán
Journal:  J Urban Health       Date:  2007-05       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.